logo
Weather page
GET THE APP
ePaper
google_play
app_store
  • Login
  • E-Edition
  • News
  • Sports
  • Obituaries
  • Opinion
  • Classifieds
    • All Listings
    • Jobs
    • Place an Ad
  • SPECIAL SECTIONS
  • PHOTO GALLERY
  • CONTESTS
  • LIFESTYLE/ENTERTAINMENT
  • GAMES
  • CATTARAUGUS COUNTY SOURCE
    • NEWS
      • LOCAL
      • STATE
      • NATION
    • SPORTS
      • LOCAL
      • NATIONAL
    • OBITUARIES
    • OPINION
      • NEWS
        • LOCAL
        • STATE
        • NATION
      • SPORTS
        • LOCAL
        • NATIONAL
      • OBITUARIES
      • OPINION
    logo
    • Classifieds
      • Place an Ad
      • All Listings
      • Jobs
    • E-Edition
    • Subscribe
    • Login
      • Classifieds
        • Place an Ad
        • All Listings
        • Jobs
      • E-Edition
      • Subscribe
      • Login
    Reported tornado causes damage in Great Valley
    Breaking News
    Reported tornado causes damage in Great Valley
    June 10, 2025
    GREAT VALLEY — Another wave of severe storms passed through the area Monday evening, with a reported tornado causing significant damage to homes and o...
    {"to-print":"To Print", "website":"Website"}
    Home

    Salamanca Press

    Posts
    Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide
    Press Releases
    Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide
    Palatin Technologies, Inc. 
    April 18, 2025
    CRANBURY, N.J. , April 17, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class...
    Read More...
    {"website":"Website"}
    Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide
    Press Releases
    Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide
    Palatin Technologies, Inc. 
    April 17, 2025
    CRANBURY, N.J. , April 17, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class...
    Read More...
    {"website":"Website"}
    Palatin Appeals NYSE American Notice of Delisting
    Press Releases
    Palatin Appeals NYSE American Notice of Delisting
    Palatin Technologies, Inc. 
    April 14, 2025
    CRANBURY, N.J. , April 14, 2025 /PRNewswire/ --Palatin Technologies, Inc. (the "Company") (NYSE American: PTN), a biopharmaceutical company developing...
    Read More...
    {"website":"Website"}
    Palatin Technologies, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to Appeal
    Press Releases
    Palatin Technologies, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to Appeal
    Palatin Technologies, Inc. 
    April 10, 2025
    CRANBURY, N.J. , April 10, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (the "Company") (NYSEAmerican:PTN), a biopharmaceutical company developing ...
    Read More...
    {"website":"Website"}
    Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
    Press Releases
    Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
    Palatin Technologies, Inc. 
    April 10, 2025
    CRANBURY, N.J. , April 10, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class...
    Read More...
    {"website":"Website"}
    Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study
    Press Releases
    Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study
    Palatin Technologies, Inc. 
    March 31, 2025
    CRANBURY, N.J. , March 31, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class...
    Read More...
    {"website":"Website"}
    Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177
    Press Releases
    Palatin Announces Positive Topline Results from Phase 2 Ulcerative Colitis (UC) Study of Oral Melanocortin-1 Receptor Agonist PL8177
    Palatin Technologies, Inc. 
    March 28, 2025
    CRANBURY, N.J. , March 28, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class...
    Read More...
    {"website":"Website"}
    Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update
    Press Releases
    Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update
    Palatin Technologies, Inc. 
    February 13, 2025
    CRANBURY, N.J. , Feb. 13, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class ...
    Read More...
    {"website":"Website"}
    Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025
    Press Releases
    Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025
    Palatin Technologies, Inc. 
    February 10, 2025
    CRANBURY, N.J. , Feb. 10, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2025 opera...
    Read More...
    {"website":"Website"}
    Local & Social

    Get in touch with The Salamanca Press

    Submit Content
    Submit News Send a Letter to the Editor Place Wedding Announcement
    Advertise
    Place Birth Announcement Place Anniversary Announcement Place Obituary
    Subscribe
    Start a Subscription e-Edition Contact Us
    Illinois Hancock Journal-Pilot Iroquois Times-Republic Journal-Republican The News-Gazette
    Indiana Fountain Co. Neighbor Herald Journal KV Post News Newton Co. Enterprise Rensselaer Republican Review-Republican
    Iowa Atlantic News Telegraph Audubon Advocate-Journal Barr's Post Card News Burlington Hawk Eye Collector's Journal Fayette County Union Ft. Madison Daily Democrat Independence Bulletin-Journal Keokuk Daily Gate City Oelwein Daily Register Vinton Newspapers Waverly Newspapers
    Michigan Iosco County News-Herald Ludington Daily News Oceana's Herald-Journal Oscoda Press White Lake Beacon New York Finger Lakes Times Olean Times Herald Salamanca Press
    Pennsylvania Bradford Era Clearfield Progress Courier Express Free Press Courier Jeffersonian Democrat Leader Vindicator Potter Leader-Enterprise The Wellsboro Gazette
    © Copyright The Salamanca Press 639 Norton Drive, Olean, NY 14760  | Terms of Use  | Privacy Policy
    Powered by TECNAVIA